Azemi Barama

CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS

J.J. Roy, Julie Lajoie, Lynn S. Zijenah et al. · Drug Metabolism and Disposition · 2005 · 179 citations

Life Sciences, Genetics, Pharmacokinetics +12

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients

Jean Nicholas Roy, Azemi Barama, Charles Poirier et al. · Pharmacogenetics and Genomics · 2006 · 115 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Renal Cell Carcinoma in Kidney Allografts: A Case Series from a Single Center

Azemi Barama, G St-Louis, Viviane Nicolet et al. · American Journal of Transplantation · 2005 · 106 citations · Full text

Medicine, Nephrology, Surgery +15

Targeting Complement Pathways During Cold Ischemia and Reperfusion Prevents Delayed Graft Function

Z.- X. Yu, Sihua Qi, M. Lasaro et al. · American Journal of Transplantation · 2016 · 48 citations · Full text

Medicine, Immunology, Surgery +17

ABSORPTION PROFILING OF CYCLOSPORINE THERAPY FOR DE NOVO KIDNEY TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED STUDY COMPARING SPARSE SAMPLING TO TROUGH MONITORING.

Azemi Barama, Ferenc Perner, Lyse Beauregard-Zollinger et al. · Transplantation · 2000 · 48 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +12